Foralumab
Product Specifications
UNSPSC Description
Foralumab (NI-0401) is a potent, orally active human monoclonal antibody targeting the CD3. Foralumab modulates immune responses by human cells in NSG mice that were reconstituted with human hematopoietic stem cells[1].
Target Antigen
CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/foralumab.html
Purity
98.08
Solubility
10 mM in DMSO
Smiles
[Foralumab]
References & Citations
[1]Ogura M, et, al. Oral treatment with foralumab, a fully human anti-CD3 monoclonal antibody, prevents skin xenograft rejection in humanized mice. Clin Immunol. 2017 Oct;183:240-246.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99199/Foralumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99199/Foralumab-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
946415-64-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1031641-01 0.02 mg (E-Coli)
Recombinant Brevibacillus brevis Imidazole glycerol phosphate synthase subunit HisF (hisF)
Ask
View Details 
MBS1031641-02 0.1 mg (E-Coli)
Recombinant Brevibacillus brevis Imidazole glycerol phosphate synthase subunit HisF (hisF)
Ask
View Details MBS1031641-03 0.02 mg (Yeast)
Recombinant Brevibacillus brevis Imidazole glycerol phosphate synthase subunit HisF (hisF)
Ask
View Details MBS1031641-04 0.1 mg (Yeast)
Recombinant Brevibacillus brevis Imidazole glycerol phosphate synthase subunit HisF (hisF)
Ask
View Details